Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.

PHASE4CompletedINTERVENTIONAL
Enrollment

388

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

January 31, 2004

Conditions
Diabetes Mellitus
Interventions
DRUG

Rosiglitazone

DRUG

spironolactone

DRUG

hydrochlorothiazide

DRUG

frusemide

Trial Locations (46)

1090

GSK Investigational Site, Brussels

2900

GSK Investigational Site, Hellerup

9170

GSK Investigational Site, Sint-Gillis-Waas

10676

GSK Investigational Site, Athens

16132

GSK Investigational Site, Genoa

21045

GSK Investigational Site, Milan

28035

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

40138

GSK Investigational Site, Bologna

41460

GSK Investigational Site, Neuss

54201

GSK Investigational Site, Dommartin-lès-Toul

55116

GSK Investigational Site, Mainz

66440

GSK Investigational Site, Blieskastel

69115

GSK Investigational Site, Heidelberg

70021

GSK Investigational Site, Acquavive Delle Fonti (BA)

75877

GSK Investigational Site, Paris

80636

GSK Investigational Site, Munich

80805

GSK Investigational Site, Munich

81241

GSK Investigational Site, Munich

R3E 3P4

GSK Investigational Site, Winnipeg

DK-8000

GSK Investigational Site, Aarhus

DK-2650

GSK Investigational Site, Hvidovre

01307

GSK Investigational Site, Dresden

564 29

GSK Investigational Site, N. Efkarpia, Thessaloniki

184 54

GSK Investigational Site, Nikaia Piraeus

Unknown

GSK Investigational Site, Jerusalem

GSK Investigational Site, Oslo

GSK Investigational Site, Tromsø

GSK Investigational Site, Olsztyn

GSK Investigational Site, Alicante

GSK Investigational Site, Newcastle upon Tyne

GSK Investigational Site, London

06126

GSK Investigational Site, Perugia

3584 CJ

GSK Investigational Site, Utrecht

N-4011

GSK Investigational Site, Stavanger

15-276

GSK Investigational Site, Bialystok

31-501

GSK Investigational Site, Krakow

90-153

GSK Investigational Site, Lodz

03-242

GSK Investigational Site, Warsaw

813 69

GSK Investigational Site, Bratislava

041 90

GSK Investigational Site, Košice

034 91

GSK Investigational Site, Ľubochňa

08022

GSK Investigational Site, Barcelona

08097

GSK Investigational Site, Barcelona

08221

GSK Investigational Site, Tarrasa, Barcelona

CV22 5PX

GSK Investigational Site, Rugby

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY